Insulet to Present at Upcoming Investor Conferences
24 Agosto 2023 - 7:00AM
Business Wire
Insulet Corporation (NASDAQ: PODD) (Insulet), the global leader
in tubeless insulin pump technology with its Omnipod® brand of
products, today announced that management will present at three
upcoming investor conferences (all Eastern Time):
- The 2023 Wells Fargo Healthcare Conference on Thursday,
September 7, 2023 at 9:30 a.m.
- The Baird 2023 Global Healthcare Conference on Tuesday,
September 12, 2023 at 2:35 p.m.
- The Morgan Stanley 21st Annual Global Healthcare Conference on
Wednesday, September 13, 2023 at 1:35 p.m.
To listen to the live audio webcasts of the presentations,
please visit investors.insulet.com/events. Replays of the webcasts
will also be available following the event.
About Insulet Corporation:
Insulet Corporation (NASDAQ: PODD), headquartered in
Massachusetts, is an innovative medical device company dedicated to
simplifying life for people with diabetes and other conditions
through its Omnipod product platform. The Omnipod Insulin
Management System provides a unique alternative to traditional
insulin delivery methods. With its simple, wearable design, the
disposable Pod provides up to three days of non-stop insulin
delivery, without the need to see or handle a needle. Insulet’s
latest innovation, the Omnipod® 5 Automated Insulin Delivery
System, is a tubeless automated insulin delivery system, integrated
with a continuous glucose monitor to manage blood sugar with no
multiple daily injections, zero fingersticks, and is fully
controlled by a compatible personal smartphone. Insulet also
leverages the unique design of its Pod by tailoring its Omnipod
technology platform for the delivery of non-insulin subcutaneous
drugs across other therapeutic areas. For more information, please
visit: Insulet.com and Omnipod.com.
©2023 Insulet Corporation. Omnipod and Omnipod 5 are registered
trademarks of Insulet Corporation.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230824533600/en/
Investor Relations:
Deborah R. Gordon Vice President, Investor Relations (978)
600-7717 dgordon@insulet.com
Media:
Angela Geryak Wiczek Senior Director, Corporate Communications
(978) 932-0611 awiczek@insulet.com
Insulet (NASDAQ:PODD)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
Insulet (NASDAQ:PODD)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024